Literature DB >> 8912747

The effect of atrial natriuretic peptide on pulmonary acid injury in a pig model.

M Tanabe1, M Ueda, M Endo, M Kitajima.   

Abstract

The effect of exogenous atrial natriuretic peptide (ANP) on pulmonary injury induced by aspiration of hydrochloric acid (0.1 N HCl, 2.0 ml/kg) was examined in anesthetized pigs ventilated with 100% oxygen. Group-specific diuretic treatment was used 60 min after aspiration and followed for a further 120 min. No diuretics were used for Group 1, 0.1 microg/kg/min of ANP was infused intravenously for 60 min in Group 2, and 0.05 mg/kg of furosemide was injected (intravenous bolus) in Group 3. Total urine volume after diuretic treatment did not differ significantly between Groups 2 and 3. However, the increase in PaO2 (to 386.3 +/- 67.5 mm Hg) after infusion of ANP was significantly higher than the increase in PaO2 (to 275.9 +/- 63.3 mm Hg) after furosemide treatment, and in the no treatment control (to 171.1 +/- 31.5 mm Hg). Pulmonary hypertension induced by acid aspiration was significantly reduced (p < 0.01 versus Groups 1 and 3) during ANP infusion. ANP has a beneficial effect on acute lung injury, possibly through its diuretic and/or pulmonary vasodilating action.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8912747     DOI: 10.1164/ajrccm.154.5.8912747

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  7 in total

1.  Atrial natriuretic peptide protects against Staphylococcus aureus-induced lung injury and endothelial barrier dysfunction.

Authors:  Junjie Xing; Nurgul Moldobaeva; Anna A Birukova
Journal:  J Appl Physiol (1985)       Date:  2010-11-04

2.  Human atrial natriuretic peptide ameliorates LPS-induced acute lung injury in rats.

Authors:  Hironori Koga; Satoshi Hagiwara; Chihiro Shingu; Shigekiyo Matsumoto; Isao Yokoi; Takayuki Noguchi
Journal:  Lung       Date:  2010-04-08       Impact factor: 2.584

3.  Effectiveness of human atrial natriuretic peptide supplementation in pulmonary edema patients using the pulse contour cardiac output system.

Authors:  Yuichiro Sakamoto; Kunihiro Mashiko; Nobuyuki Saito; Hisashi Matsumoto; Yoshiaki Hara; Noriyoshi Kutsukata; Hiroyuki Yokota
Journal:  Yonsei Med J       Date:  2010-05       Impact factor: 2.759

Review 4.  Compartmentalization of cyclic nucleotide signaling: a question of when, where, and why?

Authors:  Kavisha Arora; Chandrima Sinha; Weiqiang Zhang; Aixia Ren; Chang Suk Moon; Sunitha Yarlagadda; Anjaparavanda P Naren
Journal:  Pflugers Arch       Date:  2013-04-19       Impact factor: 3.657

5.  Epac/Rap and PKA are novel mechanisms of ANP-induced Rac-mediated pulmonary endothelial barrier protection.

Authors:  Anna A Birukova; Tatiana Zagranichnaya; Elena Alekseeva; Gary M Bokoch; Konstantin G Birukov
Journal:  J Cell Physiol       Date:  2008-06       Impact factor: 6.384

Review 6.  Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.

Authors:  Emily J Tsai; David A Kass
Journal:  Pharmacol Ther       Date:  2009-03-21       Impact factor: 12.310

7.  Atrial natriuretic peptide infusion and nitric oxide inhalation in patients with acute respiratory distress syndrome.

Authors:  A J Bindels; J G van der Hoeven; P H Groeneveld; M Frölich; A E Meinders
Journal:  Crit Care       Date:  2001-04-20       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.